Home > Qtrly Results > VENUS REMEDIES

VENUS REMEDIES
Quarterly Results Analysis [Dec2024]

VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Quarterly Results

Consolidated Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Revenues ₹177 Cr ₹167 Cr ₹109 Cr ₹195 Cr ₹143 Cr ₹168 Cr ₹95 Cr ₹156 Cr
Expenses ₹159 Cr ₹163 Cr ₹97 Cr ₹176 Cr ₹131 Cr ₹150 Cr ₹85 Cr ₹131 Cr
Operating Income ₹18 Cr ₹5 Cr ₹11 Cr ₹19 Cr ₹12 Cr ₹18 Cr ₹10 Cr ₹25 Cr
Other Income ₹2 Cr ₹11 Cr ₹2 Cr ₹4 Cr ₹2 Cr ₹3 Cr ₹2 Cr ₹3 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹5 Cr ₹6 Cr ₹6 Cr ₹6 Cr ₹7 Cr ₹6 Cr ₹8 Cr ₹8 Cr
Profit Before Tax ₹25 Cr ₹9 Cr ₹7 Cr ₹17 Cr ₹8 Cr ₹14 Cr ₹5 Cr ₹20 Cr
Profit After Tax ₹20 Cr ₹4 Cr ₹1 Cr ₹11 Cr ₹7 Cr ₹10 Cr ₹1 Cr ₹11 Cr
EPS ₹14.66 ₹2.63 ₹0.91 ₹7.86 ₹5.12 ₹7.43 ₹0.88 ₹8.27
Industry Peers & Returns1W1M1Y
VENUS REMEDIES 24.5% 21.8% -9.1%
SUN PHARMACEUTICAL INDUSTRIES 0.6% -2.1% 16.5%
CIPLA 3.6% 0.2% 2.3%
DR REDDYS LABORATORIES 3% -8.4% 0%
ZYDUS LIFESCIENCES 3.2% -1% 27.4%
DIVIS LABORATORIES 4.3% 6.5% 63.9%
MANKIND PHARMA -2.5% -8% 16.5%
TORRENT PHARMACEUTICALS 2.9% -0.5% 19.4%
LUPIN 8.2% 0.4% 37%

VENUS REMEDIES Quarterly Revenues

Revenues
Q-o-Q

5.62 %

Y-o-Y

23.32 %

Quarters Revenues % Change
Dec2024 ₹177 Cr
5.62
Sep2024 ₹167 Cr
54.18
Jun2024 ₹109 Cr
-44.35
Mar2024 ₹195 Cr
36.08
Dec2023 ₹143 Cr
-14.49
Sep2023 ₹168 Cr
76.27
Jun2023 ₹95 Cr
-38.87
Mar2023 ₹156 Cr -

VENUS REMEDIES Quarterly Operating Profit

Operating Profit
Q-o-Q

273.93 %

Y-o-Y

52.49 %

Quarters Operating Profit % Change
Dec2024 ₹18 Cr
273.93
Sep2024 ₹5 Cr
-56.39
Jun2024 ₹11 Cr
-42.20
Mar2024 ₹19 Cr
61.79
Dec2023 ₹12 Cr
-32.17
Sep2023 ₹18 Cr
70.67
Jun2023 ₹10 Cr
-57.74
Mar2023 ₹25 Cr -
Operating Margins
Q-o-Q

254.27 %

Y-o-Y

23.72 %

Quarters Operating Margin% % Change
Dec2024 10.38%
254.27
Sep2024 2.93%
-71.75
Jun2024 10.37%
3.91
Mar2024 9.98%
18.95
Dec2023 8.39%
-20.70
Sep2023 10.58%
-3.20
Jun2023 10.93%
-30.87
Mar2023 15.81% -

VENUS REMEDIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

458.40 %

Y-o-Y

186.13 %

Quarters Profit After Tax % Change
Dec2024 ₹20 Cr
458.40
Sep2024 ₹4 Cr
187.70
Jun2024 ₹1 Cr
-88.39
Mar2024 ₹11 Cr
53.43
Dec2023 ₹7 Cr
-31.09
Sep2023 ₹10 Cr
742.37
Jun2023 ₹1 Cr
-89.33
Mar2023 ₹11 Cr -
PAT Margins
Q-o-Q

427.62 %

Y-o-Y

131.80 %

Quarters PAT Margin(%) % Change
Dec2024 11.08 %
427.62
Sep2024 2.1 %
87.50
Jun2024 1.12 %
-79.22
Mar2024 5.39 %
12.76
Dec2023 4.78 %
-19.39
Sep2023 5.93 %
378.23
Jun2023 1.24 %
-82.56
Mar2023 7.11 % -

VENUS REMEDIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

457.41 %

Y-o-Y

186.33 %

Quarters EPS % Change
Dec2024 ₹14.66
457.41
Sep2024 ₹2.63
189.01
Jun2024 ₹0.91
-88.42
Mar2024 ₹7.86
53.52
Dec2023 ₹5.12
-31.09
Sep2023 ₹7.43
744.32
Jun2023 ₹0.88
-89.36
Mar2023 ₹8.27 -

You may also like the below Video Courses